A Study of Rivaroxaban (JNJ-39039039) on the Venous Thromboembolic Risk in Post-Hospital Discharge Patients

Clinical trial NCT02111564 · COMPLETED

Trial details

NCT number: NCT02111564
Sponsor: Janssen Research & Development, LLC
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Heart Failure Respiratory Insufficiency Stroke Acute Infectious Diseases Rheumatic Diseases

Start date: 2014-01-07
Primary completion: 2018-03-06
Enrollment: 12024

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.